Literature DB >> 21129643

[Projected incidence and mortality from urologic cancer in France in 2010.].

X Rébillard1, P Grosclaude, T Lebret, J-J Patard, C Pfister, P Richaud, J Rigaud, L Salomon, M Soulié.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21129643     DOI： 10.1016/S1166-7087(10)70041-5

Source DB:  PubMed          Journal:  Prog Urol        ISSN： 1166-7087            Impact factor:   0.915


× No keyword cloud information.
  3 in total

1.  National trends and differences in morbidity among surgical approaches for radical prostatectomy in Germany.

Authors:  Jens Uwe Stolzenburg; Iason Kyriazis; Claus Fahlenbrach; Christian Gilfrich; Christian Günster; Elke Jeschke; Gralf Popken; Lothar Weißbach; Christoph von Zastrow; Hanna Leicht
Journal:  World J Urol       Date:  2016-03-24       Impact factor: 4.226

2.  Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL.

Authors:  Charles Dariane; Chloé Le Cossec; Sarah J Drouin; Benoit Wolff; Benjamin Granger; Pierre Mozer; Marc-Olivier Bitker; Shahrokh F Shariat; Olivier Cussenot; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-04-26       Impact factor: 4.226

3.  HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.

Authors:  Anne-Laure Couderc; Patrick Villani; Julie Berbis; Emilie Nouguerède; Dominique Rey; Dominique Rossi; Éric Lechevallier; Delphine Badinand; Cyrille Bastide; Gilles Karsenty; Romain Boissier; Kahena Amichi; Xavier Muracciole
Journal:  BMC Cancer       Date:  2022-01-18       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.